GHK-Cu 50mg Product Overview

GHK-Cu 50mg provides a clearly identified quantity of copper peptide in a sealed research vial. The 50mg presentation may suit established laboratory programmes requiring sufficient material for repeated analytical procedures, comparative peptide investigations or longer-term experimental work.

GHK is formed from three amino acids:

• Glycine: the smallest naturally occurring amino acid
• Histidine: an amino acid capable of participating in metal-ion coordination
• Lysine: a positively charged amino acid found in many biologically active peptides

When the GHK tripeptide forms a complex with copper ions, it is known as GHK-Cu. Researchers should review the product label and batch documentation to confirm the precise material, analytical specification and quantity associated with the vial being purchased.

• Contains 50mg of GHK-Cu research material
• Supplied in a sealed laboratory vial
• Suitable for controlled analytical research
• Relevant to copper-binding peptide investigations
• Clearly labelled for inventory management
• Batch documentation available where applicable
• Not intended for human or veterinary use

What Is GHK-Cu?

GHK-Cu is the copper complex of the naturally occurring tripeptide glycyl-L-histidyl-L-lysine. GHK has been identified in human plasma and other biological fluids and demonstrates a strong affinity for copper ions.

The ability of GHK to bind copper has made the complex an established subject of biochemical research. Copper participates in several cellular and enzymatic processes, while peptide binding may influence how the metal ion is transported, stabilised or presented within an experimental system.

GHK-Cu has been investigated in laboratory and preclinical models relating to extracellular-matrix regulation, fibroblast activity, collagen synthesis, glycosaminoglycan production, oxidative stress and inflammatory signalling. Some topical studies have also examined copper-tripeptide formulations, although findings should be interpreted according to the formulation, delivery method and study design involved.

The existence of published research does not establish that a laboratory vial is suitable for clinical, personal or cosmetic use. This product is supplied solely as a research material.

Why Is GHK-Cu Studied?

Scientific interest in GHK-Cu is linked to its copper-binding properties and its reported interactions with cellular processes involved in tissue structure and remodelling. Researchers use controlled models to examine how the compound behaves under specific experimental conditions.

Potential areas of scientific investigation include:

• Copper-ion binding and coordination
• Peptide-metal complex formation
• Dermal fibroblast activity
• Extracellular-matrix regulation
• Collagen-related laboratory models
• Glycosaminoglycan synthesis
• Oxidative and inflammatory signalling
• Cellular gene-expression responses
• Tissue-remodelling pathways
• Peptide stability and degradation

These areas describe topics examined in scientific research rather than guaranteed effects or approved medical applications. Experimental findings may vary according to the model, concentration, peptide quality, delivery system and analytical method selected.

Why Choose a 50mg GHK-Cu Vial?

The 50mg quantity may be appropriate for laboratories carrying out an established programme involving multiple analytical runs or repeated controlled experiments. A larger vial can support more extensive research while reducing the need to procure several smaller units.

GHK-Cu 50mg may suit:

• Repeated chromatographic procedures
• Mass spectrometry investigations
• Analytical method development
• Comparative copper-peptide studies
• Controlled in-vitro models
• Stability and degradation testing
• Longer-term laboratory programmes
• Institutional research inventories

Researchers should estimate the total quantity required before ordering. Choosing an unnecessarily large presentation may lead to extended storage or surplus material, while insufficient stock may require additional batches to be introduced during the project.

GHK-Cu 50mg Product Details

Potential Laboratory Applications

Copper-Binding Research

GHK-Cu can be examined as part of biochemical studies involving peptide-metal coordination. Researchers may investigate complex formation, molecular stability and how environmental factors influence the relationship between the peptide sequence and its copper ion.

Fibroblast and Extracellular-Matrix Models

Published laboratory research has examined GHK-Cu in relation to dermal fibroblasts and extracellular-matrix components. These studies may consider collagen-related pathways, glycosaminoglycans, metalloproteinases and other processes associated with matrix regulation.

Oxidative and Inflammatory Signalling

Preclinical investigations have explored the potential interactions between GHK-Cu and oxidative or inflammatory processes. These findings remain dependent on the experimental system and should not be converted into claims of clinical efficacy.

Peptide Stability Analysis

Researchers may evaluate GHK-Cu under controlled environmental conditions to assess changes in chromatographic purity, molecular identity or degradation over time. Stability findings should only be applied to the conditions and samples included in the study.

Comparative Peptide Studies

GHK-Cu may be compared with uncomplexed GHK or other copper-binding peptides to examine how peptide sequence and metal coordination influence analytical and cellular characteristics.

GHK-Cu 50mg Compared with Other Apex Pharma Products

GHK-Cu and retatrutide are structurally different research compounds associated with separate scientific pathways. GHK-Cu is a short copper-binding tripeptide complex, while retatrutide is an investigational peptide studied for activity at GLP-1, GIP and glucagon receptors.

Products belonging to different research categories should not be treated as interchangeable. The compound, quantity and presentation should be selected according to the objectives and approved procedures of the individual laboratory project.

Batch Testing and Product Documentation

Batch-specific analytical documentation can help laboratories assess whether the material supplied corresponds with the expected research compound. Depending on the testing programme, a Certificate of Analysis or independent report may include identity, purity and molecular-mass information.

Researchers should review:

• The stated product name
• The batch or lot number
• The date of analysis
• The analytical methods used
• The reported chromatographic purity
• The expected and observed molecular mass
• The physical appearance of the sample
• The testing laboratory’s details
• The measured quantity where assessed

Any documentation should relate specifically to the current GHK-Cu 50mg batch. Results from a previous production run, another presentation or a different peptide should not automatically be applied to the vial being purchased.

Understanding Identity, Purity and Quantity

Identity, purity and quantity are separate analytical characteristics. A report confirming one of these does not necessarily confirm the others.

• Identity testing assesses whether analytical signals correspond with the expected GHK-Cu compound.
• Purity testing estimates the relative proportion of the principal detected material under the selected analytical method.
• Quantity testing measures how much target research material is present in the submitted sample.

A high chromatographic purity percentage should not automatically be interpreted as confirmation of total vial content, sterility, endotoxin status or suitability for administration. Researchers should evaluate the complete report and remain within the scope of the tests performed.

Storage and Laboratory Handling

GHK-Cu 50mg should be stored according to the product label and accompanying technical documentation. Product-specific instructions should always take priority over general information.

General laboratory considerations include:

• Following the stated storage temperature
• Keeping the vial sealed until required
• Protecting the material from moisture
• Avoiding unnecessary exposure to light
• Preventing unsuitable temperature fluctuations
• Recording the batch number and date received
• Restricting access to authorised personnel
• Maintaining accurate inventory records
• Following approved disposal procedures

Preparation, analysis and disposal should only be undertaken by trained personnel using suitable laboratory equipment, documented procedures and appropriate protective measures.

Who Is GHK-Cu 50mg Intended For?

GHK-Cu 50mg is intended for suitably equipped individuals and organisations with the knowledge and facilities needed to handle research peptides responsibly.

Potential purchasers may include:

• Analytical laboratories
• University research departments
• Biotechnology organisations
• Contract research laboratories
• Peptide-analysis specialists
• Cellular research facilities
• Scientific procurement teams

The product is not intended for consumers seeking a medical, cosmetic, wellness or personal-use product. Purchasing and handling must remain consistent with applicable legislation and institutional research procedures.

Why Buy GHK-Cu 50mg from Apex Pharma?

Apex Pharma supplies clearly identified peptide products for controlled scientific investigation. GHK-Cu 50mg provides a substantial vial-based presentation for laboratories conducting analytical, biochemical or cellular research.

Researchers choosing Apex Pharma can benefit from:

• Clearly stated product quantities
• Secure vial-based presentations
• Batch documentation where available
• Independent analytical testing where applicable
• Clear research-use labelling
• UK-based customer support
• Reliable nationwide delivery
• A growing research peptide range

The wider Apex Pharma catalogue also includes Reta 20mg, Reta Pen 20mg and Reta Pen 40mg. Researchers should examine the product information, presentation size and batch documentation associated with each item before ordering.

Frequently Asked Questions